HydraSynol™ DOI ( INCI: Isosorbide Dicaprylate ) is now REACH registered in Europe for an annual use level of 100 tons.
REACH registration for HydraSynol™ DOI has been a major achievement for Sytheon considering the challenge faced by cosmetic ingredient manufacturers in fulfilling the Toxicity & Eco-toxicity requirements for high volume approval. HydraSynol™ DOI is approved for use as a cosmetic ingredient in Japan, Korea and many other countries except China.
HydraSynol™ DOI is a well-defined lipophilic compound and is one of the best cost-effective solutions for improving Skin Hydration and Barrier Homeostasis on the market today. HydraSynol™ DOI is naturally derived, ECOCERT approved material. Clinically, HydraSynol™ DOI has been proven to be very effective in providing long-term and controlled Skin Hydration and works synergistically with glycerol.
Key attributes of HydraSynol™ DOI:
- Smart Skin Hydrator – Helps transport moisture where it is needed for the best results
- Supports in restoring & enhancing skin’s natural moisture retention mechanisms
- Brings back skin homeostasis by stimulating E-Cadherin